Ulla T. Schultheiß

Current Position

Junior Group Leader and Clinical Resident (Human Genetics Practice)

Academic Education

1999 - 2007

Medical School, Albert-Ludwigs-University, Freiburg, Germany

Advanced Qualifications

2006	Doctoral degree in Medicine (Dr. med.), University of Freiburg

Postgraduate Positions

2021-present	Residency, Human Genetics Practice (Synlab MVZ Humangenetik, Prof. J. Kohlhase, Prof. J. Decker)
2021-present	Part of the ClinGen Gene Curation Expert Panel for curating genes associated with genetically determined cystic kidney diseases
2020-present	Junior-group-leader of ‘CKDNapp’ (https://ckdn.app/): a junior consortium funded by the German Federal Ministry of Education and Research (BMBF) within the framework of the e:Med research and funding concept
2019-present	Speaker of the endpoint-committee diabetes within the GNC study
2018-2019	Investigator German National Cohort (GNC), Institute for Prevention and Tumorepidemiology, Medical Center – University of Freiburg (Prof. Dr. Dr. K. Michels)
2017-present	Research Scientist, Institute of Genetic Epidemiology, Medical Center – University of Freiburg (Prof. Dr. A. Köttgen)
2010-present	Investigator German Chronic Kidney Disease study, Department of Nephrology, Medical Center - University of Freiburg (Prof. Dr. A. Köttgen, advisor)
2007-2008	Clinical resident, Renal Division, Medical Center - University of Freiburg (Prof. Dr. G. Walz)
2003-2004	Pediatric Nephrology, University of Michigan, Ann Arbor, USA: Dissertation: Nephrocystin-5, a ciliary IQ domain protein, is mutated in Senior-Loken syndrome and interacts with RPGR and calmodulin

Link to all publications of Ulla T. Schultheiß: PubMed

Publications on CRC 1453 funding

Schumann A, Schultheiss UT, Ferreira CR, Blau N. Clinical and biochemical footprints of inherited metabolic diseases. XIV. Metabolic kidney diseases. Mol Genet Metab (2023). Schlosser P, Scherer N, Grundner-Culemann F, Monteiro-Martins S, Haug S, …, Wuttke M, …, Köttgen M, …, Schmidts M, …, Schultheiss UT, …, Sekula P, Li Y, Köttgen A. Genetic studies of paired metabolomes reveal enzymatic and transport processes at the interface of plasma and urine. Nat Genet (2023). Steinbrenner I, Yu Z, Jin J, Schultheiss UT, Kotsis F, …, Wuttke M, …, Chatterjee N, Sekula P, Köttgen A. A polygenic score for reduced kidney function and adverse outcomes in a cohort with chronic kidney disease. Kidney international (2022). Steinbrenner I, Sekula P, Kotsis F, von Cube M, Cheng Y, …, Eckardt KU, Schultheiss UT, GCKD investigators. Association of osteopontin with kidney function and kidney failure in chronic kidney disease patients: the GCKD study. Nephrol Dial Transplant (2022). Li Y, Cheng Y, Consolato F, Schiano G, Chong MR, …, Sekula P, Steinbrenner I, Schlosser P, …, Schultheiss UT, …, Wuttke M, …, Devuyst O, Rampoldi L, Köttgen A. Genome-wide studies reveal factors associated with circulating uromodulin and its relations with complex diseases. JCI Insight (2022). Cheng Y, Li Y, Scherer N, Grundner-Culemann F, Lehtimäki T, …, Sekula P, Schultheiss UT; GCKD investigators. Genetics of osteopontin in patients with chronic kidney disease: The German Chronic Kidney Disease study. PLoS Genet (2022). Kotsis F, Schultheiss UT, Wuttke M, Schlosser P, Mielke J, …, Sekula P, Köttgen A, GCKD Investigators. Self-Reported Medication Use and Urinary Drug Metabolites in the German Chronic Kidney Disease (GCKD) Study. J Am Soc Nephrol (2021).